A Meta-Analysis of 16 Randomized Trials of Sirolimus-Eluting Stents Versus Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease
Albert Schömig(Institut für Umwelttechnologien und Strahlenschutz (Germany)), Adnan Kastrati(Deutsches Herzzentrum München), Alban Dibra(Deutsches Herzzentrum der Charité), Peter Jüni(University of Oxford), Stephan Windecker(University of Bern), José Suárez de Lezo(Hospital Universitario Reina Sofía), Julinda Mehilli, Bernhard Meier(University of Bern), Jae‐Hwan Lee(Hyosung Corporation (South Korea)), Jinjin Wu(Deutsches Herzzentrum der Charité), Seung‐Jung Park(Samsung Medical Center), Matthias Pfisterer(University Hospital of Basel), Emilio Di Lorenzo(Azienda Ospedaliera S.Giuseppe Moscati), Christoph Kaiser(University of Basel), Jean-Jacque Goy(Hirslanden Clinique Cecil)
Cited by 356
Related Papers
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
|European Heart Journal|2015|8.3k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
Guidelines on the management of valvular heart disease (version 2012)
|European Heart Journal|2012|3.6k